Compound Summary
D-Xyl
Compound Information
D-Xyl
Compound Name: | D-Xyl |
Compound CID: | 135191 |
Synonyms: | D-Xyl D-Xylopyranose D-Xylopyranoside D-Xylose Xyl More... |
Iupac Name: | (3R,4S,5R)-oxane-2,3,4,5-tetrol |
InChI: | InChI=1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3+,4-,5?/m1/s1 |
InChIKey: | SRBFZHDQGSBBOR-IOVATXLUSA-N |
Canonical Smiles: | C1C(C(C(C(O1)O)O)O)O |
Isomeric Smiles: | C1[C@H]([C@@H]([C@H](C(O1)O)O)O)O |
Molecular Weight: | 150.13 |
Molecular Formula: | C5H10O5 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
D-Xyl
Molecular Weight: | 150.13 |
Molecular Formula: | C5H10O5 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 10 |
Complexity: | 117 |
Synonyms
D-Xyl
| D-Xyl | D-Xyl |
|---|---|
D-Xyl |
D-Xylopyranose |
D-Xylopyranoside |
D-Xylose |
Xyl |
Xylopyranose |
Xylopyranoside |
Xylose |
Wood sugar |
d-(+)-Xylose |
Xyloside |
(3R,4S,5R)-oxane-2,3,4,5-tetrol |
7261-26-9 |
D-xylopentose |
CHEBI:53455 |
D(+)-XYLOSE |
Xylopyranose (6CI,7CI,8CI,9CI) |
10257-31-5 |
Xylomed |
50855-32-8 |
(3R,4S,5R)-tetrahydro-2H-pyran-2,3,4,5-tetrol |
D-(+)-Xylose, >=99% |
Xylose (USP) |
Xylo-Pfan (TN) |
(3R,4S,5R)-Tetrahydro-2H-pyran-2,3,4,5-tetraol |
DSSTox_CID_3745 |
Epitope ID:114701 |
DSSTox_RID_77180 |
DSSTox_GSID_23745 |
SCHEMBL39891 |
MLS001361339 |
CHEMBL502135 |
cid_135191 |
DTXSID0023745 |
BDBM16234 |
D-(+)-Xylose, analytical standard |
Tox21_302055 |
MFCD00064360 |
AKOS025401342 |
D-(+)-Xylose, BioXtra, >=99% |
D-(+)-Xylose, puriss., 98.5% |
CAS-58-86-6 |
D-(+)-Xylose, 99%, natural sourced |
NCGC00165998-01 |
NCGC00255319-01 |
AC-11300 |
AS-11757 |
SMR000857378 |
C00181 |
D06346 |
058X866 |
D-(+)-Xylose, SAJ special grade, 98.0-101.0% |
F8887-9207 |
rel-(3R,4S,5R)-Tetrahydro-2H-pyran-2,3,4,5-tetraol |
WURCS=2.0/1,1,0/a212h-1x_1-5/1/ |
Xylose, European Pharmacopoeia (EP) Reference Standard |
Xylose, United States Pharmacopeia (USP) Reference Standard |
D-(+)-Xylose, BioUltra, >=99.0% (sum of enantiomers, HPLC) |
Experimental Data
D-Xyl
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 10.000000000000000 | mM | 6.000000000000000 | S | N2 | 25643626 | Active |
Experimental Data Visualization
D-Xyl
Statistics Data
D-Xyl
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 6.000000000000000 | 1 | 1 |
Statistics Data Visualization
D-Xyl
